| Detected | Trial | Change |
|---|---|---|
| 2026-08-15 | NCT07007559 ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in… |
Trial sites expanded: 44 -> 54 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2/3 | |||
| NCT05002127 | A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06) | Gastric Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT07007559 | ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in… | Breast Cancer, Metastatic | Recruiting |
| NCT04675294 | Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and… | Head and Neck Cancer | Active, Not Recruiting |
| NCT04675333 | Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With… | Head and Neck Cancer | Active, Not Recruiting |
| Phase 1 | |||
| NCT07085091 | A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors | NSCLC (Advanced Non-small Cell Lung Cancer) | Recruiting |